» Articles » PMID: 10655102

Agonists of Proteinase-activated Receptor 2 Induce Inflammation by a Neurogenic Mechanism

Overview
Journal Nat Med
Date 2000 Feb 2
PMID 10655102
Citations 273
Authors
Affiliations
Soon will be listed here.
Abstract

Trypsin and mast cell tryptase cleave proteinase-activated receptor 2 and, by unknown mechanisms, induce widespread inflammation. We found that a large proportion of primary spinal afferent neurons, which express proteinase-activated receptor 2, also contain the proinflammatory neuropeptides calcitonin gene-related peptide and substance P. Trypsin and tryptase directly signal to neurons to stimulate release of these neuropeptides, which mediate inflammatory edema induced by agonists of proteinase-activated receptor 2. This new mechanism of protease-induced neurogenic inflammation may contribute to the proinflammatory effects of mast cells in human disease. Thus, tryptase inhibitors and antagonists of proteinase-activated receptor 2 may be useful anti-inflammatory agents.

Citing Articles

Identification of a secreted protease from that induces intestinal pain and inflammation by cleavage of PAR.

Lakemeyer M, Latorre R, Blazkova K, Jensen D, Wood H, Shakil N bioRxiv. 2025; .

PMID: 39868234 PMC: 11761754. DOI: 10.1101/2025.01.15.633241.


From bite to brain: Neuro-immune interactions in food allergy.

Houghton V, Eiwegger T, Florsheim E, Knibb R, Thuret S, Santos A Allergy. 2024; 79(12):3326-3340.

PMID: 39462229 PMC: 11657076. DOI: 10.1111/all.16366.


Update on the Role of β2AR and TRPV1 in Respiratory Diseases.

Manti S, Gambadauro A, Galletta F, Ruggeri P, Piedimonte G Int J Mol Sci. 2024; 25(19).

PMID: 39408565 PMC: 11477158. DOI: 10.3390/ijms251910234.


Update on protease-activated receptor 2 in inflammatory and autoimmune dermatological diseases.

Xu K, Wang L, Lin M, He G Front Immunol. 2024; 15:1449126.

PMID: 39364397 PMC: 11446762. DOI: 10.3389/fimmu.2024.1449126.


The JAK1/JAK2 inhibitor ruxolitinib inhibits mediator release from human basophils and mast cells.

Poto R, Cristinziano L, Criscuolo G, Strisciuglio C, Palestra F, Lagnese G Front Immunol. 2024; 15:1443704.

PMID: 39188724 PMC: 11345246. DOI: 10.3389/fimmu.2024.1443704.